Skip to main content
Equibles

Woodline Partners LP

Position in TGTX — Tg Therapeutics, Inc.

CIK 1784547 San Francisco, CA
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$39,309,570
+$15,540,660 QoQ
Shares Held
715,500
0.0% QoQ
Ownership
0.467%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#28
of 426 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. TGTX ranks #37 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in TGTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,309,570 715,500
2026-03-31 $23,768,910 715,500
2025-06-30 $21,400,373 594,620
2025-03-31 $21,021,473 533,134
2024-09-30 $60,002,881 2,565,322
2024-06-30 $25,253,509 1,419,534
2024-03-31 $21,363,920 1,404,597
2023-12-31 $30,204,852 1,768,434
2023-09-30 $1,271,882 152,139
2023-06-30 $3,514,860 141,500
2022-12-31 $30,309,643 2,562,100
2022-09-30 $5,531,861 934,436
2021-09-30 $3,558,696 106,932
2021-06-30 $3,955,804 101,980
2021-03-31 $44,670,121 926,766
2020-12-31 $1,729,769 33,252
2020-09-30 $5,348,655 199,875
2020-06-30 $6,480,060 332,652